Calendar Merck KGaA

Equities

MRK

DE0006599905

Market Closed - Xetra 16:35:15 18/06/2024 BST 5-day change 1st Jan Change
169.2 EUR -1.23% Intraday chart for Merck KGaA -1.54% +17.38%

Chart calendar Merck KGaA

b4bd9e3682c0cb4c.rxATZJz2uxaGcfu-NiN6M9i4r1SbDNliq6YCgWN01t8.53F8LuyY_kWrNs7WeWlJRrvPlmCqbrgt79A2yFQtn-frYHcLzIbWbvM-tg~cef00f78737547dc26694180173b6c1f

Upcoming events on Merck KGaA

31/07/2024 Q2 2024 Earnings Call
01/08/2024 06:00 Q2 2024 Earnings Release
16/10/2024 Capital Markets Day
13/11/2024 Q3 2024 Earnings Call
14/11/2024 06:00 Q3 2024 Earnings Release
05/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)
30/07/2025 Q2 2025 Earnings Release (Projected)
12/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Merck KGaA

03/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract No - 8575
03/06/2024 16:12 American Society of Clinical Oncology Meeting - Abstract No - 4508
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No - 3018
03/06/2024 14:00 R&D Day
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No - 4567
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No - 4566
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No - TPS6126
01/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract No - LBA3559
01/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract No - 3550
01/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No - 2614
01/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No - 2612
01/06/2024 09:00 American Society of Clinical Oncology Meeting - Abstract No - 3000
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - e18039
15/05/2024 13:00 Q1 2024 Earnings Call
15/05/2024 06:00 Q1 2024 Earnings Release
28/04/2024 Détachement de for final dividend
26/04/2024 09:00 Annual General Meeting
07/03/2024 13:00 Q4 2023 Earnings Call
07/03/2024 06:00 Q4 2023 Earnings Release
08/01/2024 17:00 JPMorgan Healthcare Conference

Past dividends on Merck KGaA

28/04/2024 Annual 2.2 EUR
01/05/2023 Annual 2.2 EUR
24/04/2022 Annual 1.85 EUR
25/04/2021 Annual 1.4 EUR
28/05/2020 Annual 1.3 EUR
28/04/2019 Annual 1.25 EUR
29/04/2018 Annual 1.25 EUR
01/05/2017 Annual 1.2 EUR
01/05/2016 Annual 1.05 EUR
19/04/2015 Annual 1 EUR

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
16 152
16 092
0.37%
17 534
17 407
0.73%
19 687
19 632
0.28%
22 232
22 259
-0.12%
20 993
21 026
-0.16%

21 324

EBITDA
Million EUR
Released
Forecast
Spread
4 385
4 335
1.15%
5 201
5 081
2.36%
6 103
6 096
0.12%
6 849
6 898
-0.71%
5 879
5 823
0.97%

5 964

EBIT
Million EUR
Released
Forecast
Spread
2 120
2 262
-6.29%
2 985
2 985
-0.01%
4 179
4 150
0.69%
4 474
4 933
-9.29%
3 609
3 730
-3.24%

4 033

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
1 735
1 928
-9.99%
2 630
2 726
-3.52%
3 924
3 886
0.97%
4 287
4 727
-9.3%
3 484
3 695
-5.72%

3 817

Net income
Million EUR
Released
Forecast
Spread
1 320
1 448
-8.85%
1 987
1 999
-0.57%
3 055
2 986
2.3%
3 326
3 674
-9.48%
2 824
2 831
-0.26%

2 997

EPS
EUR
Released
Forecast
Spread
3,04
3,36
-9.47%
4,57
4,62
-1.11%
7,03
6,89
2.1%
7,65
8,46
-9.54%
6,49
6,50
-0.22%

6,88

Announcement Date05/03/2004/03/2103/03/2202/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million EUR
Released
Forecast
Spread
8 489
8 553
-0.75%
5 198
5 218
-0.38%
5 568
5 417
2.79%
5 806
5 695
1.95%
5 660
5 698
-0.66%
5 293
5 254
0.73%
5 302
5 221
1.55%
5 173
5 255
-1.56%
5 225
5 248
-0.44%
5 120
5 144
-0.47%

5 262


5 415


5 547

EBITDA
Million EUR
Released
Forecast
Spread
2 256
2 232
1.06%
1 629
1 631
-0.15%
1 782
1 709
4.27%
1 811
1 795
0.85%
1 628
1 658
-1.83%
1 587
1 550
2.41%
1 553
1 511
2.76%
1 446
1 369
5.66%
1 293
1 256
2.95%
1 454
1 354
7.38%

1 428


1 513


1 695

EBIT
Million EUR
Released
Forecast
Spread



1 173
1 198
-2.07%
1 177
1 248
-5.66%
1 234
1 319
-6.45%
890
1 241
-28.29%
1 035
1 124
-7.95%
969
1 028
-5.7%
983
903
8.89%
621
750
-17.18%
931
815
14.21%

833


1 078


1 086

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread



1 139
1 131
0.74%
1 122
1 207
-7.05%
1 187
1 266
-6.26%
839
1 202
-30.19%
1 012
1 088
-7.01%
894
981
-8.88%
937
850
10.29%
641
839
-23.56%
899
785
14.55%

807


1 053


1 063

Net income
Million EUR
Released
Forecast
Spread



880
880
0.02%
867
931
-6.86%
923
980
-5.76%
655
967
-32.26%
796
825
-3.53%
704
765
-8%
739
658
12.37%
586
647
-9.4%
694
657
5.6%

699


824


875

EPS
EUR
Released
Forecast
Spread
1,72
1,86
-7.53%
2,02
2,02
-0.16%
1,99
2,13
-6.65%
2,12
2,27
-6.43%
1,51
2,22
-32.06%
1,83
1,90
-3.6%
1,62
1,76
-8.06%
1,70
1,54
10.21%
1,34
1,50
-10.42%
1,60
1,52
5.02%

1,60


1,91


2,02

Announcement Date06/08/2012/05/2204/08/2210/11/2202/03/2311/05/2303/08/2309/11/2307/03/2415/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW